Study of plasma methylated septin 9 as a biomarker of follow-up monitoring and prognosis in colorectal cancer
The utility of plasma methylated septin 9 (mSEPT9) as a biomarker for colorectal cancer (CRC) surveillance is underexplored. The aim of this study was to evaluate its role in recurrence […]